Next Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $3.24M | Sell |
23,907
-2,662
| -10% | -$314K | 0.21% | 96 |
|
|
2021
Q3 | $2.87M | Buy |
26,569
+1,208
| +5% | +$138K | 0.22% | 99 |
|
|
2021
Q2 | $2.86M | Buy |
25,361
+1,558
| +7% | +$175K | 0.23% | 103 |
|
|
2021
Q1 | $2.58M | Buy |
23,803
+4,751
| +25% | +$508K | 0.23% | 96 |
|
|
2020
Q4 | $2.04M | Sell |
19,052
-433
| -2% | -$41.6K | 0.2% | 118 |
|
|
2020
Q3 | $1.71M | Sell |
19,485
-112
| -0.6% | -$10.5K | 0.18% | 123 |
|
|
2020
Q2 | $1.92M | Buy |
19,597
+1,832
| +10% | +$161K | 0.22% | 117 |
|
|
2020
Q1 | $1.35M | Buy |
17,765
+2,071
| +13% | +$176K | 0.17% | 125 |
|
|
2019
Q4 | $1.39M | Buy |
15,694
+868
| +6% | +$72.1K | 0.14% | 164 |
|
|
2019
Q3 | $1.12M | Sell |
14,826
-82
| -0.6% | -$5.62K | 0.12% | 220 |
|
|
2019
Q2 | $1.08M | Buy |
14,908
+9,161
| +159% | +$720K | 0.12% | 212 |
|
|
2019
Q1 | $463K | Sell |
5,747
-8,545
| -60% | -$699K | 0.12% | 129 |
|
|
2018
Q4 | $1.32M | Buy |
14,292
+7,349
| +106% | +$646K | 0.27% | 92 |
|
|
2018
Q3 | $657K | Sell |
6,943
-3,284
| -32% | -$311K | 0.3% | 68 |
|
|
2018
Q2 | $948K | Sell |
10,227
-1,797
| -15% | -$175K | 0.36% | 72 |
|
|
2018
Q1 | $1.14M | Buy |
12,024
+270
| +2% | +$29.7K | 0.24% | 113 |
|
|
2017
Q4 | $1.14M | Sell |
11,754
-6,810
| -37% | -$642K | 0.49% | 58 |
|
|
2017
Q3 | $1.68M | Sell |
18,564
-4,811
| -21% | -$366K | 0.47% | 48 |
|
|
2017
Q2 | $1.7M | Sell |
23,375
-284
| -1% | -$19.1K | 0.41% | 48 |
|
|
2017
Q1 | $1.56M | Sell |
23,659
-2,117
| -8% | -$133K | 0.43% | 48 |
|
|
2016
Q4 | $1.61M | Buy |
25,776
+1,105
| +4% | +$67.4K | 0.28% | 77 |
|
|
2016
Q3 | $1.56M | Buy |
24,671
+6,980
| +39% | +$452K | 0.28% | 82 |
|
|
2016
Q2 | $1.09M | Buy |
17,691
+516
| +3% | +$31.4K | 0.35% | 73 |
|
|
2016
Q1 | $981K | Buy |
17,175
+713
| +4% | +$39.7K | 0.35% | 72 |
|
|
2015
Q4 | $975K | Sell |
16,462
-867
| -5% | -$49.9K | 0.36% | 65 |
|
|
2015
Q3 | $942K | Sell |
17,329
-2,381
| -12% | -$155K | 0.34% | 75 |
|
|
2015
Q2 | $1.32M | Sell |
19,710
-1,309
| -6% | -$85.5K | 0.46% | 51 |
|
|
2015
Q1 | $1.23M | Buy |
21,019
+844
| +4% | +$51K | 0.39% | 63 |
|
|
2014
Q4 | $1.32M | Sell |
20,175
-8,581
| -30% | -$541K | 0.44% | 46 |
|
|
2014
Q3 | $1.66M | Sell |
28,756
-814
| -3% | -$45.2K | 0.33% | 59 |
|
|
2014
Q2 | $1.56M | Buy |
+29,570
| New | +$1.55M | 0.81% | 21 |
|
Other funds holding ABBV
Next Financial Group's ABBV Position: Q4 2021 in Review
Next Financial Group reduced its AbbVie (ABBV) stake by 10% in Q4 2021, selling an estimated $314K and leaving 23,907 shares worth $3.24M. The position accounts for 0.21% of the portfolio, ranked #96.
Next Financial Group first reported a position in ABBV in Q2 2014 and has held it in 31 quarters since. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.
- Next Financial Group held 23,907 shares of AbbVie worth $3.24M as of Q4 2021.
- Next Financial Group sold 2,662 AbbVie shares in Q4 2021, an estimated $314K.
- AbbVie made up 0.21% of Next Financial Group's portfolio in Q4 2021, its #96 holding.
- Next Financial Group first reported a position in AbbVie in Q2 2014 and has held it in 31 quarters since.
- 2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.